IDEX Corporation (IEX) Balance Sheet

The reduction in debt alongside a stable equity base of roughly $4.0B lowers the debt-to-equity ratio from 0.55 to 0.44, which appears to reflect disciplined repayment rather than equity-driven balance sheet expansion. The improvement is meaningful but partly reflects the 2024Q3 acquisition-driven debt spike rolling off, so investors should monitor whether leverage continues to trend lower or stabilizes as new bolt-on deals are funded. Total assets of roughly $6.9B have been largely flat since 2024Q3, suggesting that balance sheet strengthening has come from liability management rather than asset growth.

The current leverage level appears deliberate rather than constrained, given that IEX's $1.8B of total debt is modest relative to its roughly $949M in annual revenue run-rate and its reported operating margins above 20%. This suggests the company retains meaningful borrowing capacity for acquisitions without materially increasing refinancing risk. Investors should note that the ratio is elevated relative to the most conservative peers such as Xylem and Franklin Electric, so the balance sheet is strong but not unique in the peer set.

A current ratio near 2.8 still indicates comfortable coverage of short-term obligations, and cash of roughly $600M provides a meaningful buffer against operating shocks. The downward drift from the mid-3s, however, may reflect higher current liabilities or lower current assets as acquisition integration and working capital normalize. This warrants monitoring, though it does not currently suggest any liquidity strain.

The composition points to a business model built on serial acquisitions, where value is embedded in purchased intellectual property and customer relationships rather than physical plant. This makes tangible book value thin relative to reported equity and means that any future impairment charge would fall directly on equity. Investors should monitor goodwill carrying amounts closely, as the magnitude of intangibles here elevates impairment sensitivity if end-market growth in life sciences or fire and safety softens.